BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 43 filers reported holding BRIDGEBIO PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,039,375 | +257.6% | 21,875,000 | +191.7% | 0.87% | +237.5% |
| Q2 2023 | $5,882,850 | +25849.9% | 7,500,000 | -75.3% | 0.26% | -68.9% |
| Q1 2023 | $22,670 | +20.5% | 30,329,000 | -35.9% | 0.83% | +60.8% |
| Q4 2022 | $18,813 | -99.9% | 47,329,000 | +2.4% | 0.52% | +35.6% |
| Q3 2022 | $27,183,000 | +12.3% | 46,229,000 | 0.0% | 0.38% | -30.7% |
| Q2 2022 | $24,197,000 | -16.4% | 46,229,000 | -6.1% | 0.55% | -18.1% |
| Q1 2022 | $28,932,000 | +97.4% | 49,229,000 | +111.9% | 0.67% | +110.3% |
| Q4 2021 | $14,657,000 | -49.5% | 23,229,000 | +10.6% | 0.32% | -58.3% |
| Q3 2021 | $29,010,000 | -64.4% | 21,000,000 | -57.7% | 0.77% | -66.1% |
| Q2 2021 | $81,551,000 | -1.2% | 49,655,000 | 0.0% | 2.26% | -31.3% |
| Q1 2021 | $82,515,000 | – | 49,655,000 | – | 3.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 141,500,000 | $63,675,000 | 2.13% |
| ARISTEIA CAPITAL, L.L.C. | 156,841,000 | $70,578,450 | 1.41% |
| Affinity Asset Advisors, LLC | 7,500,000 | $3,410,048 | 1.34% |
| CONTRARIAN CAPITAL MANAGEMENT, L.L.C. | 8,500,000 | $3,782,500 | 0.94% |
| TFG Asset Management GP Ltd | 10,000,000 | $4,623,611 | 0.66% |
| Context Capital Management, LLC | 17,035 | $7,890 | 0.58% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 47,329,000 | $18,813 | 0.52% |
| SILVERBACK ASSET MANAGEMENT LLC | 5,000,000 | $2,287,850 | 0.32% |
| MACKAY SHIELDS LLC | 14,611,000 | $6,574,950 | 0.17% |
| Ionic Capital Management LLC | 1,400,000 | $644,740 | 0.15% |